RxDoctor Payments DataLook up a doctor →

Alexia Gospodinoff, MD

Rheumatology · Reston, VANPI 1578630869

Payments from drug & device makers

$26,775in general payments, 2019–2025

Across 1,335 payments — averaging $20.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$4K
  • AbbVie$4K
  • Johnson & Johnson$3K
  • Novartis$2K
  • UCB, Inc.$2K
  • Lilly USA, LLC$2K
  • plus $9K from 33 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen(2 entities)209$4,226
AbbVie187$4,144
Johnson & Johnson136$2,971
Novartis117$2,486
UCB, Inc.127$1,994
Lilly USA, LLC87$1,513
AstraZeneca(2 entities)49$1,134
GSK48$1,086
E.r. Squibb & Sons, L.L.C.51$979
Pfizer51$936
Radius Health, Inc.52$700
Genentech USA, Inc.34$613
ANI Pharmaceuticals, Inc.40$608
Aurinia Pharma U.S., Inc.17$535
Mallinckrodt Enterprises LLC15$448
Mallinckrodt Hospital Products Inc.19$446
Bristol Myers Squibb22$328
Sanofi10$307
Regeneron Healthcare Solutions, Inc.12$253
Fresenius Kabi USA, LLC8$194
Pacira Therapeutics, Inc.6$138
Cumberland Pharmaceuticals, Inc.4$107
Boehringer Ingelheim4$102
Hikma Pharmaceuticals USA5$65
Celltrion USA Inc.3$61
Actelion Pharmaceuticals US, Inc.3$49
Sobi, Inc2$47
Fidia Pharma USA Inc.3$44
Pacira Pharmaceuticals Incorporated2$38
Sandoz2$33
Idorsia Pharmaceuticals US Inc2$32
Takeda Pharmaceuticals U.S.A., Inc.1$28
Scilex Pharmaceuticals Inc.1$25
Organon1$25
Supernus Pharmaceuticals, Inc.1$20
Ultragenyx Pharmaceutical Inc.1$19
Ascend Therapeutics US, LLC1$18
Eisai Inc.1$12
Medexus Pharma, Inc.1$11

How this compares

$26,775 in reported general payments places this provider in the 90th percentile of 159 rheumatology providers in Virginia.

See all rheumatology providers in Virginia →

Medicare billing

Part B allowed, 2024
$1,929,010
Medicare patients
647
Services billed
149,366

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other rheumatology in Reston

See the full list for Virginia →

Where these figures come from

Is this you, or does something look wrong? →